New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems.
20h
MyChesCo on MSNFDA Approves TREMFYA® for Crohn’s Disease, Offering New Treatment OptionsHORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results